Novel synthetic drugs for the treatment of non-Hodgkin lymphoma

F Manji, R Puckrin, DA Stewart - Expert Opinion on …, 2021 - Taylor & Francis
Introduction: Over the past two decades, deeper understanding of B-cell signaling pathways
and other mechanisms of lymphomagenesis have yielded promising targets for novel drugs …

[HTML][HTML] Targeting Epigenetic Modifiers Can Reduce the Clonogenic Capacities of Sézary Cells

A Chebly, M Prochazkova-Carlotti, Y Idrissi… - Frontiers in …, 2021 - frontiersin.org
Sézary syndrome (SS) is an aggressive leukemic variant of cutaneous T-cell lymphomas
(CTCL) in which the human Telomerase Reverse Transcriptase (hTERT) gene is re …

[HTML][HTML] Epigenetics and sphingolipid metabolism in health and disease

W Wang, PT Toran, R Sabol, TJ Brown… - International journal of …, 2018 - ncbi.nlm.nih.gov
Sphingolipids represent one of the major classes of bioactive lipids. Studies of sphingolipids
have intensified in the past several years, revealing their roles in nearly all cell biological …

Review and prospect of tissue-agnostic targeted strategies in anticancer therapies

Y Peng, H Tao, Y Gao, Y Yang… - Current Topics in …, 2021 - ingentaconnect.com
Due to the increasing prevalence of cancer year by year, and the complexity and refractory
nature of the disease itself, it is required to constantly innovate the development of new …

HDAC inhibitors in cancer therapy

A Ganesan - Histone Modifications in Therapy, 2020 - Elsevier
Reversible lysine acetylation is a major posttranslational modification in histones and
nonhistone proteins. Modulation of this process is an important target for drug discovery …

Recalcitrant Subcutaneous Panniculitis-Like T-Cell Lymphoma Responsive to Histone Deacetylase Inhibitor

L Gleason, D Joffe, S Bhatti, A Cohen… - Case Reports in …, 2022 - karger.com
Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a rare subtype of cutaneous T-
cell lymphoma that usually presents with tender subcutaneous nodules on the trunk and …

Exploring the Chemical Reactivity andBioactivity of Romidepsin: A CDFT-BasedComputational Peptidology Study

N Flores-Holguín, J Frau, D Glossman-Mitnik - 2023 - researchsquare.com
Romidepsin is a cyclic peptide derived from a natural product that has shown remarkable
therapeutic potential for the treatment of cancer and other diseases. In this study, we employ …

Generación de un modelo de silenciamiento del gen HDAC1

M Lillo Valero - 2023 - riunet.upv.es
[ES] En las últimas décadas se han aportado múltiples evidencias que demuestran que el
cáncer no es sólo una enfermedad de carácter genético, sino que los mecanismos …

Untersuchungen zur Expression von humanen endogenen Retroviren (HERVs) in chemotherapie-refraktären Mammakarzinomen

L Reinold - 2023 - hss-opus.ub.ruhr-unibochum.de
Humane endogene Retroviren (HERVs) wurden während der Evolution durch Infektionen
mit exogenen Retroviren in unser Genom integriert. Eine Vielzahl dieser Elemente wird …

Epigenetics in Cancer Biology

RA Stein, AN Deverakonda - Cancer Research: An Interdisciplinary …, 2023 - Springer
The term epigenetics dates back to the 1940s, when Conrad Waddington introduced it to
refer to gene expression changes that occur during development and do not involve …